Fig. 4From: Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysisSubgroup meta-analysis of the association between antidiabetic treatments and MACE stratified by drug classes in patients with uncontrolled diabetes (HbA1c > 8%) and better controlled diabetes (HbA1c ≤ 8%)Back to article page